The American College of Cardiology’s Annual Meeting features the “latest updates in the field with a focus on transforming cardiovascular care for all!” (ACC.org). This year, we’re sharing the conference headlines from CV News Digest, the official daily news briefing for ACC members that we produce in partnership with ACC, to bring our readers up to speed on ACC.25.
This year’s meeting included numerous research and therapeutic breakthroughs, with emphasis on advancements in heart failure treatment, diabetes-related cardiovascular risks, anticoagulation strategies, structural heart interventions, and more. Read on for the top highlights covered in CV News Digest!
Heart Failure Management
- Dapagliflozin Reduced Mortality, Heart Failure Worsening In High-Risk Older Adults Getting TAVR, Trial Shows
MedPage Today
- Restricted Vs Liberal Fluid Restriction Did Not Impact Health Status Of Patients With HF, Trial Finds
MedPage Today
- Bilateral Oophorectomy Linked To Increased Risk For Heart Failure, Study Finds
HealthDay
Aortic Stenosis & Valve Therapy
- TAVR And Surgery Conferred Similar Rates Of Death, Disabling Stroke At 5 Years In Patients With Severe Aortic Stenosis At Low Surgical Risk, Data Show
Healio
- Routine Cerebral Embolic Protection Did Not Reduce Incidence Of Stroke At 72 Hours In Patients Undergoing TAVR, Trial Finds
Healio
Diabetes and Cardiovascular Disease
- High-Risk Patients With T2D Plus Established ASCVD, CKD, Or Both Have Fewer Major Adverse Cardiovascular Events When Treated With A GLP-1 Receptor Agonist Compared With Usual Care, Trial Shows
TCTMD
- Semaglutide Injections Increased Walking Ability Of People With T2D And Lower Limb PAD, Research Finds
MedPage Today
Antithrombotic Therapy
- Lower Dose Of Apixaban Was Just As Effective As Higher Dose For Extended Anticoagulation After VTE In Patients With Active Cancer, Trial Shows
MedPage Today
- Patients Hospitalized For Heart Attack Who Were Treated With Rivaroxaban For Left Ventricular Thrombus Had Comparable Outcomes At 3 Months To Patients Treated With Warfarin, Trial Finds
Healio
- Three Months Of DAPT After PCI May Safely Balance Thrombosis, Bleeding Risk In Both Patients With Low And High Bleeding Risk, Compared With 1 And 12 Months Of DAPT, Data Indicate
Healio
Women’s Cardiovascular Health
- Intensive Medical Therapy, Compared With Usual Care, Fails To Reduce Risk Of Cardiovascular Events At 5 Years In Women With INOCA, Trial Finds
TCTMD
Medical Imaging Technology
- GE HealthCare Launches Next-Generation CT Scanner For CCTA, Structural Heart Exams
Cardiovascular Business
For more industry insights like this, follow us on LinkedIn and Instagram!
